JP2002521046A - 遺伝子工学的に操作された細胞および組織 - Google Patents

遺伝子工学的に操作された細胞および組織

Info

Publication number
JP2002521046A
JP2002521046A JP2000562057A JP2000562057A JP2002521046A JP 2002521046 A JP2002521046 A JP 2002521046A JP 2000562057 A JP2000562057 A JP 2000562057A JP 2000562057 A JP2000562057 A JP 2000562057A JP 2002521046 A JP2002521046 A JP 2002521046A
Authority
JP
Japan
Prior art keywords
cells
cell
gene
expression
gene product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000562057A
Other languages
English (en)
Japanese (ja)
Inventor
ノートン、ゲイル、ケイ．
マンスブリッジ、ジョナサン、エヌ．
Original Assignee
アドバンスド ティシュー サイエンシズ，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アドバンスド ティシュー サイエンシズ，インコーポレーテッド filed Critical アドバンスド ティシュー サイエンシズ，インコーポレーテッド
Publication of JP2002521046A publication Critical patent/JP2002521046A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2000562057A 1998-07-28 1999-07-28 遺伝子工学的に操作された細胞および組織 Pending JP2002521046A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9440898P 1998-07-28 1998-07-28
US60/094,408 1998-07-28
PCT/US1999/016961 WO2000006204A2 (fr) 1998-07-28 1999-07-28 Cellules genetiquement modifiees et tissus

Publications (1)

Publication Number Publication Date
JP2002521046A true JP2002521046A (ja) 2002-07-16

Family

ID=22245006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000562057A Pending JP2002521046A (ja) 1998-07-28 1999-07-28 遺伝子工学的に操作された細胞および組織

Country Status (6)

Country Link
EP (1) EP1100548A2 (fr)
JP (1) JP2002521046A (fr)
KR (1) KR20010085313A (fr)
AU (1) AU5321299A (fr)
CA (1) CA2338487A1 (fr)
WO (1) WO2000006204A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014200182A (ja) * 2013-04-03 2014-10-27 国立大学法人 東京大学 培地及び細胞の培養方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403205A1 (fr) * 2000-03-13 2001-09-20 Engene, Inc. Compositions et methodes destinees a l'expression regulee d'une proteine dans l'intestin
DE10019195B4 (de) * 2000-04-17 2006-03-09 Heart Biosystems Gmbh Reversible Immortalisierung
AU2007285472B2 (en) 2006-03-30 2013-10-24 Engene, Inc. Non-viral compositions and methods for transfecting gut cells in vivo
KR101372966B1 (ko) * 2009-01-23 2014-03-13 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 표적 세포 유도용 피더 세포
AU2019387218A1 (en) * 2018-11-26 2021-06-03 Massachusetts Institute Of Technology Compositions and methods for immune tolerance
CN114724643A (zh) * 2021-01-06 2022-07-08 腾讯科技（深圳）有限公司 一种多肽化合物的筛选方法以及相关装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
GB9402857D0 (en) * 1994-02-15 1994-04-06 Isis Innovation Targeting gene therapy
CA2270160A1 (fr) * 1996-11-08 1998-05-14 Oklahoma Medical Research Foundation Expression specifique de l'endothelium regulee par des elements regulateurs du recepteur epcr
ES2157874T1 (es) * 1998-06-02 2001-09-01 Univ Washington Implante protesico y procedimientos de utilizacion para la expresion de un gen terapeutico.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014200182A (ja) * 2013-04-03 2014-10-27 国立大学法人 東京大学 培地及び細胞の培養方法

Also Published As

Publication number Publication date
WO2000006204A2 (fr) 2000-02-10
CA2338487A1 (fr) 2000-02-10
WO2000006204A3 (fr) 2000-05-04
AU5321299A (en) 2000-02-21
EP1100548A2 (fr) 2001-05-23
KR20010085313A (ko) 2001-09-07

Similar Documents

Publication Publication Date Title
US5645829A (en) Mesothelial cell gene therapy
JP3452366B2 (ja) 新規人工組織、その製法およびその使用
Al-Hendy et al. Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts—an alternate approach to somatic gene therapy
US4868116A (en) Introduction and expression of foreign genetic material in epithelial cells
Vandenburgh et al. Tissue-engineered skeletal muscle organoids for reversible gene therapy
Bosch et al. Osteoprogenitor cells within skeletal muscle
US4980286A (en) In vivo introduction and expression of foreign genetic material in epithelial cells
EP0733101A1 (fr) Lignees de cellules beta a secretion d'insuline et sensibles au glucose, et procede de production
CA2115140A1 (fr) Proliferation de precurseurs d'hepatocytes
JP3244696B2 (ja) ヒト筋肉細胞の単離、増殖および分化
JPH11506611A (ja) 管、腱、靭帯および矯正構造体のための間質細胞ベースの三次元培養系
CA2330834A1 (fr) Compositions et procedes pour le traitement du diabete
Gilbert et al. Cell transplantation of genetically altered cells on biodegradable polymer scaffolds in syngeneic rats
JP2005185293A (ja) インシュリン分泌細胞系、その製造方法と使用
US20030003088A1 (en) Human pancreatic pluripotential stem cell line
JP2002521046A (ja) 遺伝子工学的に操作された細胞および組織
JP2005506084A (ja) インビトロにおけるマイクロ器官、およびそれに関する用途
Wei et al. Directed endothelial differentiation of cultured embryonic yolk sac cells in vivo provides a novel cell‐based system for gene therapy
Kanazawa et al. Transformed growth phenotype of mouse mammary epithelium in primary culture induced by specific fetal mesenchymes
Freeman et al. Culture of a prostatic cell line in basement membrane gels results in an enhancement of malignant properties and constitutive alterations in gene expression
JP3410738B2 (ja) ミクログリアからなる医薬用キャリアー
US7919080B2 (en) Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity
Yoshida et al. Proinsulin-secreting hybrid skin that can be used to treat diabetic animals
O'Malley Jr et al. DNA‐and viral‐mediated gene transfer in follicular cells: Progress toward gene therapy of the thyroid
AU701860C (en) Glucose responsive insulin secreting beta-cell lines and method for producing same